Copper Kills Escherichia coli Persister Cells

Area of Science:

• Microbiology
• Antimicrobial Resistance
• Biochemistry

Background:

• Bacterial persister cells exhibit reduced metabolism, enabling survival against conventional antimicrobial treatments targeting active pathways.
• Existing metabolism-independent anti-persister compounds, like mitomycin C and cisplatin, have limitations, necessitating the search for alternatives.
• Copper alloys possess historical antimicrobial properties and are utilized in agriculture for plant disease control.

Purpose of the Study:

• To investigate the efficacy of cupric compounds against *Escherichia coli* persister cells.
• To identify novel, cost-effective, and metabolism-independent agents for eliminating bacterial persisters.

Main Methods:

• Generation of a pure *Escherichia coli* persister cell population by inhibiting transcription with rifampicin and eliminating non-persister cells with ampicillin.
• Treatment of the isolated persister cells with cupric compounds to assess their killing efficacy.

Main Results:

• Cupric compounds were demonstrated to effectively kill *Escherichia coli* persister cells.
• Copper ions show potential as a metabolism-independent bactericidal agent against persister cells.

Conclusions:

• Copper ions represent a promising therapeutic agent for eradicating bacterial persister cells.
• This finding offers a new strategy for managing infections caused by antibiotic-resistant bacterial strains that form persister cells.
• Copper-based treatments could supplement or replace conventional antimicrobials for controlling persistent bacterial infections.